These outcomes are in alignment with prior studies, which have consistently implicated SETD8 as a proto-oncogene in a diverse array of malignancies, including but not limited to colorectal, neuroblastoma, pancreatic, breast, cervical cancers, and multiple myeloma [26]. This evidence concerns the gene KMT5A and AL amyloidosis.